Effective as of the opening of business on March 20, 2024, Classes A, C and I of the Fund will no longer be closed to new investors and will be available for purchase by all eligible investors.
Objective
Seeks long-term capital appreciation.
Overview
An international stock fund that combines the high active share and low volatility strategies of multiple managers.
The portfolio managers are supported by the full resources of Wellington.
Performance
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
SI = Since Inception.
Fund Inception: 06/30/2008
Share Class Inception: 2/28/17.
Class F-shares performance prior to 2/28/17 reflects the performance and operating expenses of Class I-shares. Performance for Class F-shares prior to its inception date would have differed if Class F- operating expenses had been reflected. Since Inception (SI) performance is calculated from 6/30/08.
Characteristics
# of Holdings | 457 |
---|---|
% in Equities | 97 |
% in Foreign Equities | 94 |
Beta (3 year) | 1.00 |
R Squared (3 year) | 0.99 |
Standard Deviation | 17.11% |
Turnover | 23% |
Active Share | 64% |
FUND | MSCI ACWI ex USA Index | |
---|---|---|
Price/Earnings | 12.3x | 12.2x |
Price/Book | 1.9x | 1.8x |
EPS Growth Rate | 14.7% | 12.7% |
Asset Weighted Market Cap (billions) | $91.0 | $106.1 |
Return on Equity | 15.9% | 16.2% |
Median Market Cap (billions) | $12.4 | $9.4 |
Japan | 14 |
France | 11 |
United Kingdom | 11 |
China | 6 |
Germany | 6 |
Canada | 5 |
Taiwan | 5 |
Switzerland | 5 |
India | 5 |
South Korea | 4 |
Taiwan Semiconductor Manufacturing Co. Ltd. | 2.89 |
Samsung Electronics Co. Ltd. | 1.46 |
Schneider Electric SE | 1.35 |
AstraZeneca PLC | 1.18 |
Tencent Holdings Ltd. | 1.12 |
Airbus SE | 1.05 |
Capgemini SE | 1.02 |
Heineken NV | 0.97 |
Novo Nordisk AS | 0.94 |
ASML Holding NV | 0.90 |
Total Portfolio % | 12.88 |
Less than $2 billion | 4 | |
$2 billion - $5 billion | 6 | |
$5 billion - $10 billion | 8 | |
Greater than $10 billion | 82 | |
Not Classified | 0 |
Alpha (5 Year)
|
-0.07 |
Down Capture (5 Year)
|
101.47 |
Information Ratio (5 Year)
|
-0.04 |
Sharpe Ratio (5 Year)
|
0.29 |
Up Capture (5 Year)
|
100.85 |
FUND |
BENCHMARK | UNDERWEIGHT / OVERWEIGHT | |||||
---|---|---|---|---|---|---|---|
12/31/23 | 3/31/24 | 3/31/24 | -4 0 4 | ||||
Consumer Staples | 10 | 10 | 7 | ||||
Communication Services | 8 | 8 | 5 | ||||
Industrials | 15 | 16 | 14 | ||||
Consumer Discretionary | 14 | 14 | 12 | ||||
Information Technology | 12 | 13 | 13 | ||||
Health Care | 10 | 9 | 9 | ||||
Materials | 6 | 6 | 7 | ||||
Real Estate | 1 | 1 | 2 | ||||
Energy | 4 | 4 | 6 | ||||
Utilities | 1 | 1 | 3 | ||||
Financials | 18 | 17 | 21 |
Insights
Fund Literature